Multi-omics Gene Set Enrichment Analysis
Multi-Omics Gene Set Enrichment Analysis · Also known as: multi-omics GSEA, integrated GSEA, cross-omics pathway enrichment, multi-layer GSEA
Multi-omics gene set enrichment analysis (multi-omics GSEA) is a computational pipeline that applies GSEA logic simultaneously across two or more molecular measurement layers — such as transcriptomics, proteomics, and metabolomics — to identify biological pathways or gene sets that are coordinately dysregulated across omics platforms. By integrating ranked molecular signatures from each layer, it reveals pathway-level convergence that no single omics platform could detect alone.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use multi-omics GSEA when you have matched omics measurements from the same samples and want to identify pathways with evidence across multiple molecular layers, particularly in disease studies, drug mechanism-of-action investigations, or systems biology experiments where a single layer provides incomplete mechanistic insight. It is most powerful when at least two high-quality omics datasets with reasonable feature coverage of curated pathways are available. Do NOT use it when omics datasets come from different patient cohorts or unmatched samples, when one layer has very poor coverage of pathway gene sets (e.g., fewer than 30% of pathway members detected), or when the research question is about a single molecular layer — standard single-platform GSEA is then more appropriate and easier to interpret.
Strengths & limitations
- Pathway-level integration is more interpretable than feature-level multi-omics analyses and directly connects to known biology.
- Cross-layer concordance dramatically reduces false-positive pathways that are noise in any single omics layer.
- Agnostic to the number of omics layers — works with two layers and scales to four or more without changing the core logic.
- Compatible with all major GSEA implementations (GSEA desktop, fgsea, GSVA, ssGSEA) and gene-set databases (MSigDB, Reactome, KEGG).
- Applicable to both bulk and, increasingly, pseudobulk single-cell datasets when cells can be aggregated per sample.
- Requires the same samples to be profiled across all omics layers; missing or partially matched samples reduce power and can introduce bias.
- Feature-to-gene mapping for proteomics and metabolomics is incomplete — unmapped features are silently excluded, potentially biasing pathway scores.
- Integration strategies (meta-analysis vs. rank aggregation) produce different shortlists; no single integration method is universally optimal.
- Pathway databases are biased toward well-studied pathways, so novel biology may not be captured regardless of the omics depth.
- Computational and data-curation overhead is substantially higher than single-platform GSEA.
Frequently asked
Can I apply multi-omics GSEA if I only have RNA-seq and proteomics data?
Yes — two layers is the minimum and is the most common use case. The integration is simpler (e.g., intersect significant gene sets or compute a mean NES) and statistical power is usually sufficient if both datasets have adequate sample sizes (typically n ≥ 10 per group).
How do I handle metabolomics features that do not map to genes?
Unmapped metabolites must be excluded from the gene-set scoring step. You can report them separately as a supplementary feature-level analysis, or use metabolite-set enrichment analysis (MSEA) against metabolite-specific pathway databases such as SMPDB or KEGG compound pathways, then cross-reference enriched metabolite pathways with enriched gene pathways manually.
Which integration method should I use — meta-analysis or rank aggregation?
There is no universally best method. Meta-analysis of NES values (weighted by sample size or variance) is intuitive and widely reported. Rank-of-ranks aggregation (e.g., RobustRankAggreg) is more conservative and less sensitive to outlier scores in one layer. If results are consistent across both methods, confidence in the hits is higher. Reporting both and highlighting the consensus is good practice.
Does the order in which I run per-layer GSEA matter?
No. Per-layer GSEA runs are independent; their outputs (NES and FDR per gene set) are combined in the integration step. The order of processing has no effect on the final integrated scores.
What sample size is needed?
GSEA is relatively robust and does not require large n, but multi-omics integration compounds batch effects and technical noise. A minimum of 10 samples per condition per layer is a reasonable working rule; fewer than 6 per condition makes NES estimates unstable. Power calculations specific to GSEA are available through the GSEApower R package.
Sources
- Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., & Mesirov, J. P. (2005). Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences, 102(43), 15545–15550. DOI: 10.1073/pnas.0506580102 ↗
- Meng, C., Zeleznik, O. A., Thallinger, G. G., Kuster, B., Gholami, A. M., & Culhane, A. C. (2016). Dimension reduction techniques for the integrative analysis of multi-omics data. Briefings in Bioinformatics, 17(4), 628–641. DOI: 10.1093/bib/bbv108 ↗
How to cite this page
ScholarGate. (2026, June 3). Multi-Omics Gene Set Enrichment Analysis. ScholarGate. https://scholargate.app/en/bioinformatics/multi-omics-gene-set-enrichment-analysis
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Gene Set Enrichment AnalysisBioinformatics↔ compare
- Multi-omics Pathway Enrichment AnalysisBioinformatics↔ compare
- Pathway Enrichment AnalysisBioinformatics↔ compare
- Proteomics AnalysisBioinformatics↔ compare
- RNA-seq Differential ExpressionBioinformatics↔ compare
- Single-cell Gene Set Enrichment AnalysisBioinformatics↔ compare